The Problems of Opioid and Other Drug Dependencies

  • Abraham Wikler


Abuse of and dependencies on drugs of all sorts (notably alcohol, cannabis, sedatives, stimulants, and tobacco), though varying in kind and in degree, are worldwide. For a sampling of drug problems through the world, the reader is referred to Peterson (1978) and to Austin et al. (1978). This chapter is concerned with problems of opioid and other drug dependencies in the United States.


Opioid Dependence Paranoid Schizophrenia Delirium Tremens Abrupt Withdrawal Abstinence Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abelson, H. I., Fishburne, P. M., and Cisin, I. H., 1977, National Survey on Drug Abuse, 1977: A Nationwide Study—Youth, Young Adults and Older Adults. Response Analysis Corporation, Princeton.Google Scholar
  2. Aivazian, G. H., 1964, Clinical evaluation of diazepam, Dis. Nerv. System 25: 491–496.Google Scholar
  3. Allen, R. M., and Young, S. J., 1978, Phencyclidine-induced psychosis. Amer. J. Psychiat.135: 1081–1084.PubMedGoogle Scholar
  4. Austin, G. A., Macari, M. A., and Lettieri, D. J. (Eds.), 1978, International Drug Use, NIDA Research Issues 23, DHEW Publication No. (ADM) 79–809. Superintendent of Documents, U.S. Government Printing Office, Washington, D.C.Google Scholar
  5. Ball, J. C., and Chambers, C. D. (Eds.), 1970, The Epidemiology of Opiate Addiction in the United States. Charles C Thomas, Springfield, Ill.Google Scholar
  6. Beckett, A. H., Gorrod, J. W., and Jenner, P., 1971, The effect of smoking on nicotine metabolism in vivoin man, J. Pharmacy Pharmacol.23 (Suppl.): 62–67.CrossRefGoogle Scholar
  7. Belleville, R. E., and Fraser, H. F., 1957, Tolerance to some effects of barbiturates, J. Pharmacol. Exp. Ther.120: 469–474.PubMedGoogle Scholar
  8. Capel, W. C., Goldsmith, B. G., Waddell, K. J., and Stewart, G. T., 1972, The aging narcotic addict: An increasing problem for the next decades, J. Gerontol.27: 102–106.PubMedGoogle Scholar
  9. Carey, J. T., and Mandel, J., 1969, A San Francisco Bay area “speed scene” in Drug Dependence, No. 2., pp. 20–29. National Clearinghouse for Mental Health Information, National Institute of Mental Health, Bethesda, Md.Google Scholar
  10. Center for New York City Affairs of the New School for Social Research, 1972, City Almanac 6: 2.Google Scholar
  11. Cherubin, C., McCusker, J., Baden, M., Kavaler, F., and Amsel, Z., 1972, The epidemiology of death in narcotic addicts, Amer. J. Epidemiol.96: 11–22.Google Scholar
  12. Cohen, L., 1966, Stiff-man syndrome. Two patients treated with diazepam, J. Amer. Med. Ass.195: 222–224.CrossRefGoogle Scholar
  13. Connell, P. H., 1958, Amphetamine Psychosis. Chapman and Hall, London.Google Scholar
  14. Deneau, G. A., and Kaymakcalan, S., 1971, Physiological and psychological dependence to synthetic O9-tetrahydrocannabinol (THC) in rhesus monkeys, Pharmacologist13: 246.Google Scholar
  15. DuPont, R. L., 1978, International challenge of drug abuse: A perspective from the United States, in The International Challenge of Drug Abuse(R. C. Petersen, Ed.), NIDA Research Monogr. 19, DHEW Publication No. (ADM) 78–654, pp. 3–4. Superintendent of Documents, U.S. Government Printing Office, Washington, D.C. 20402.Google Scholar
  16. Essig, C. F., 1964, Addiction to nonbarbiturate sedative and tranquilizing drugs, Clin. Pharmacol. Ther.5: 334–343.PubMedGoogle Scholar
  17. Essig, C. F., and Fraser, H. F., 1958, Electroencephalographic changes in man during use and withdrawal of barbiturates in moderate dosage, Electroenceph. Clin. Neurophysiol.10: 649–656.PubMedCrossRefGoogle Scholar
  18. Fraser, H. F., Wikler, A., Essig, C. F., and Isbell, H., 1958, Degree of physical dependence induced by secobarbital or pentobarbital, J. Amer. Med. Ass.166: 126–129.CrossRefGoogle Scholar
  19. Friedman, M. J., and Jaffe, H. J., 1969, A central hypothermic response to pilocarpine in the mouse, J. Pharmacol. Exp. Ther.167: 34–44.PubMedGoogle Scholar
  20. Friedman, M. J., Jaffe, J. H., and Sharpless, S. K., 1969, Central nervous system supersensitivity to pilocarpine after withdrawal of chronically administered scopolamine, J. Pharmacol. Exp. Ther.167: 45–55.PubMedGoogle Scholar
  21. Grinspoon, L., 1971, Marihuana Reconsidered, p. 246. Harvard University Press, Cambridge, Mass.Google Scholar
  22. Haertzen, C. A., and Hooks, N. T., 1969, Changes in personality and subjective experience associated with the chronic administration of opiates, J. Nerv. Ment. Dis.148: 606–614.PubMedCrossRefGoogle Scholar
  23. Haizlip, T. M., and Ewing, J. A., 1958, Meprobamate habituation. A controlled clinical study, New Engl. J. Med.258: 1181–1186.PubMedCrossRefGoogle Scholar
  24. Hirschhorn, I. D., and Rosecrans, J. A., 1974, Morphine and O9-tetrahydrocannabinol: Tolerance to the stimulus effects, Psychopharmacologia 36: 243–253.PubMedCrossRefGoogle Scholar
  25. Hollister, L. E., Motzenbecker, F. P., and Degan, R. O., 1961, Withdrawal reactions from chlordiazepoxide (Librium), Psychopharmacologia 2: 63–68.PubMedCrossRefGoogle Scholar
  26. Hollister, L. E., Bennett, J. L., Kimbell, I., Savage, C., and Overall, J. E., 1963, Diazepam in newly admitted schizophrenics, Dis. Nerv. System 24: 746–750.Google Scholar
  27. Hunt, W. A., and Matarazzo, J. D., 1973, Three years later: Recent developments in the experimental modification of smoking behavior, J. Abnorm. Psychol.82: 107–114.CrossRefGoogle Scholar
  28. Isbell, H., 1959, Comparison of the reactions produced by psilocybin and LSD-25 in man, Psychopharmacologia 1: 29–38.PubMedCrossRefGoogle Scholar
  29. Isbell, H., Altschul, S., Kornetsky, C. H., Eisenman, A. J., Flanary, H. G., and Fraser, H. F., 1950, Chronic barbiturate intoxication. An experimental study. . (Chicago) 64: 1–28.PubMedGoogle Scholar
  30. Isbell, H., Fraser, H. F., Wikler, A., Belleville, R. E., and Eiseman, A. J., 1955, An experimental study of the etiology of “rum fits” and delirium tremens. Quart. J. Stud. Alcohol 16: 1–33.PubMedGoogle Scholar
  31. Isbell, H., Belleville, R. E., Fraser, H. F., Wikler, A., and Logan, C. R., 1956, Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication, Arch. Neurol. Psychiat. (Chicago) 76: 468–478.Google Scholar
  32. Isbell, H., Wolbach, A. B., Wikler, A., and Miner, E. J., 1961, Cross tolerance between LSD and psilocybin, Psychopharamacologia 2: 147–159.CrossRefGoogle Scholar
  33. Isbell, H., Rosenberg, D. E., Miner, E. J., and Logan, C. R., 1964, Tolerance and cross-tolerance to scopolamine, N-ethyl-3-piperidyl benzylate (JB 318) and LSD-25, in Neuropsychopharmacology, Vol. 3 ( P. B. Bradley, F. Flügel, and P. Hoch, Eds.), pp. 440–446. Elsevier, Amsterdam.Google Scholar
  34. Itil, T. M., Ulett, G. A., Hsu, W., Klingenberg, H., and Ulett, J. A., 1971, The effects of smoking withdrawal on quantitatively analyzed EEG, Clin. Electroencephalog.2: 44–51.Google Scholar
  35. Jarvik, M. E., 1979, Biological influences on cigarette smoking, in The Behavioral Aspects of Smoking(N. A. Krasnegor, Ed.), NIDA Research Monogr. No. 26, DHEW Publication No. (ADM) 79–882, pp. 7–45. Superintendent of Documents, U.S. Government Printing Office, Washington, D.C.Google Scholar
  36. Jones, R. R., and Farrell, T. R., 1978, Tobacco smoking and nicotine tolerance, in Self-Administration of Abused Substances: Methods for Study(N. A. Krasnegor, Ed.), NIDA Research Monogr. No. 20, pp. 202–208. Alcohol, Drug Abuse and Mental Health Administration, Printing and Publications Management Branch, Rockville, Maryland.Google Scholar
  37. Jones, R. T., Benowitz, N., and Bachman, J., 1976, Clinical studies of cannabis tolerance and dependence, in Chronic Cannabis Use. Annals of the New York Academy of Sciences, Vol. 282 ( R. L. Dornbush, A. M. Freedman, and M. Fink, Eds.), pp. 221–239. The New York Academy of Sciences, New York.Google Scholar
  38. Kaim, S. C., and Klett, G. J., 1972, Treatment of delirium tremens. A comparison of four drugs, Quart. J. Stud. Alcohol 33: 1065–1072.PubMedGoogle Scholar
  39. Kaymakcalan, S., 1973, Tolerance to and dependence on cannabis, U.N. Bull. Narcotics 25: 39–47.Google Scholar
  40. Kaymakcalan, S., Ayhan, I. H., and Tulunay, F. C., 1977, Naloxone-induced or post-withdrawal abstinence signs in A9-tetrahydrocannabinol-tolerant rats, Psychopharmacology 55: 243–249.PubMedCrossRefGoogle Scholar
  41. Knapp, P. H., Bliss, C. M., and Wells, H., 1963, Addictive aspects in heavy cigarette smoking, Amer. J. Psychiat.119: 966–972.PubMedGoogle Scholar
  42. Knott, V. J., and Venables, P. H., 1977, EEG alpha correlates of nonsmokers, smokers, smoking and smoking deprivation, Psychophysiology 14: 150–156.PubMedCrossRefGoogle Scholar
  43. Kramer, J. C., Fischman, V. S., and Littlefield, D. C., 1967, Amphetamine abuse: Pattern and effects of high doses taken intravenously, J. Amer. Med. Ass.201: 305–309.CrossRefGoogle Scholar
  44. Kreek, M. J., 1973, Medical safety and side effects of methadone in tolerant individuals, J. Amer. Med. Ass.223: 665–668.CrossRefGoogle Scholar
  45. Kurtz, S., 1969, The New York Times Encyclopedic Almanac,1970, p. 205. Book and Educational Division, The New York Times, New York.Google Scholar
  46. Lemberger, L., Silberstein, S. D., Axelrod, J., and Kopin, I. J., 1970, Marihuana: Studies in the disposition of A9-tetrahydrocannibinol in man, Science 170170: 1320–1322.PubMedCrossRefGoogle Scholar
  47. Lemberger, L., Tamarkin, N. R., Axelrod, J., and Kopin, I. J., 1971, A9tetrahydrocannabinol: Metabolism and disposition in long-term marihuana smokers, Science 173: 72–74.PubMedCrossRefGoogle Scholar
  48. McGlothlin, W. H., 1979, Drugs and crime, in Handbook on Drug Abuse( R. I. DuPont, A. Goldstein, and J. O’Donnell, Eds.), pp. 357–364. Superintendent of Documents, U.S. Government Printing Office, Washington, D.C.Google Scholar
  49. McGlothlin, W. H., Anglin, M. D., and Wilson, B. D., 1977, An Evaluation of the California Civil Addict Program, NIDA Services Research Monogr. Series, DHEW Publ. No. (ADM) 78–558. U.S. Government Printing Office, Washington, D.C.Google Scholar
  50. Martin, W. R., Jasinski, D. R., Haertzen, C. A., Kay, D. C., Jones, B. E., Mansky, P. A. and Carpenter, R. W., 1973, Methadone—a reevaluation, Arch. Gen. Psychiat.28: 782–791.Google Scholar
  51. Miles, C. P., 1977, Conditions predisposing to suicide: A review, J. Nerv. Ment. Dis.164: 231–246.PubMedCrossRefGoogle Scholar
  52. Nurco, D. N., and DuPont, R. L., 1977, A preliminary report on crime and addiction within a community-wide population of narcotic addicts, Drug Alcohol Dependence 2: 109–121.CrossRefGoogle Scholar
  53. Donnell, J. A., Voss, H. L., Clayton, R. R., Slatin, G. T., and Room, R. G., 1976, Young Men and Drugs—A Nationwide Survey, NIDA Research Monogr. Series 5, DHEW Publication No. (ADM) 76–311. National Technical Information Service, Springfield, Va. 22161.Google Scholar
  54. Parry, H. J., 1979, Sample surveys of drug abuse, in Handbook on Drug Abuse(R. I. DuPont, A. Goldstein, and J. O’Donnell, Eds.), pp. 381–394. Superintendent of Documents, U.S. Government Printing Office, Washington, D.C. 20402.Google Scholar
  55. Paton, W. D. M., 1968, Drug dependence: A sociopharmacological assessment, Advan. Sci.25: 200–212.Google Scholar
  56. Petersen, R. C. (Ed.), 1978, The International Challenge of Drug Abuse, NIDA Research Monogr. No. 19, DHEW Publication No. (ADM) 78–654. Superintendent of Documents, U.S. Government Printing Office, Washington, D.C.Google Scholar
  57. Petersen, R. C., and Stillman, R. C., 1978, Phencyclidine: An overview, in Phencyclidine (PCP) Abuse: An Appraisal(R. C. Petersen and R. C. Stillman, Eds.), NIDA Research Monogr. No. 21, pp. 1–17. U.S. Government Printing Office, Washington, D.C.Google Scholar
  58. Pevnick, J. D., Jasinski, D. R., and Haertzen, C. A., 1978, Abrupt withdrawal from therapeutically administered diazepam, Arch. Gen. Psychiat. 35:995–998.PubMedCrossRefGoogle Scholar
  59. Pillard, R. C., 1970, Medical progress: marihuana, New Engl. J. Med.283: 294–303.CrossRefGoogle Scholar
  60. Pillard, R. C., 1971, Book review: Marihuana Reconsideredby L. Grinspoon, New Engl. J. Med.285: 416–417.CrossRefGoogle Scholar
  61. Resnick, R. B., Kestenbaum, R. S., and Schwartz, L. K., 1977, Acute systemic effects of cocaine in man: A controlled study by intranasal and intravenous routes, Science 195: 696–698.PubMedCrossRefGoogle Scholar
  62. Robbins, P. R., and Nugent, J. F., 1975, Perceived consequences of addiction: A compari- son between alcholics and heroin-addicted patients, J. Clin, Psychol. 31: 367–369.Google Scholar
  63. Robins, L. N., 1979, Addict careers, in Handbook on Drug Abuse( R. I. DuPont, A. Goldstein, and J. O’Donnell, Eds.), pp. 325–336. Superintendent of Documents, U.S. Gov ernment Printing Office, Washington, D.C.Google Scholar
  64. Sapira, J. D., 1968, The narcotic-addict as a medical patient, Amer. J. Med.4545: 555–588.PubMedCrossRefGoogle Scholar
  65. Sells, S. B., Chatham, L. R., and Retka, R. L., 1972, A study of differential death rates and causes of death among 9276 opiate addicts during 1970–1971, Contemp. Drug Probl. 1: 665–706.Google Scholar
  66. Shiffman, S. M., 1979, The tobacco withdrawal syndrome, in Cigarette Smoking as a Dependence Process(N. A. Krasnegor, Ed.), NIDA Research Monogr. Series No. 23, DHEW Publ. No. (ADM) 79–800, pp. 158–184. Alcohol, Drug Abuse, and Mental Health Administration, Printing and Publications Management Branch, Rockville, Maryland.Google Scholar
  67. Siegel, R. K., 1978, Cocaine hallucinations, Amer. J. Psychiat.135: 309–314.PubMedGoogle Scholar
  68. Soueif, M. I., 1967, Hashish consumption in Egypt, with special reference to psychosicial aspects, U.N. Bull. Narcotics 19: 1–12.Google Scholar
  69. Soueif, M. I., 1971, The use of cannabis in Egypt: A behavioural study, U.N. Bull. Narcotics 23: 17–28.Google Scholar
  70. Terry, C. E., and Pellens, M., 1928, The Opium Problem. Bureau of Social Hygiene, New York.Google Scholar
  71. Thompson, W. L., Johnson, A. D., Maddrey, W. L., and the Osier Medical Housestaff, 1975, Diazepam and paraldehyde for treatment of severe delirium tremens. A controlled trial, Ann. Int. Med.82: 175–180.PubMedGoogle Scholar
  72. Victor, M., 1976, Alcoholism, in Clinical Neurology(A. B. Baker and L. H. Baker, Eds.), Vol. 2, Chap. 22, pp. 1–43. Harper 0026 Row, New York.Google Scholar
  73. Victor, M., and Adams, R. D., 1953, The effect of alcohol on the nervous system, in Metabolic and Toxic Diseases of the Nervous System(H. H. Merritt and C. C. Hare, Eds.), Res. Publ. Ass. Nerv. Ment. Dis., Vol. 32, pp. 526–573. Williams 0026 Wilkins, Baltimore.Google Scholar
  74. Victor, M., and Brausch, C., 1967, The role of abstinence in the genesis of alcohol epilepsy, Epilepsia (Amsterdam) 8: 1–20.CrossRefGoogle Scholar
  75. Wikler, A., 1952, A psychodynamic study of a patient during self-regulated readdiction to morphine, Psychiat. Quart.26: 270–293.PubMedCrossRefGoogle Scholar
  76. Wikler, A., 1968, Diagnosis and treatment of drug dependence of the barbiturate type, Amer. J. Psychiat.125: 758–765.PubMedGoogle Scholar
  77. Wikler, A., 1974, The marijuana controversy, in Marijuana. Effects on Human Behavior( L. L. Miller, Ed.), Academic Press, New York.Google Scholar
  78. Wikler, A., 1976, Aspects of tolerance and dependence on cannabis, in Chronic Cannabis Use. Annals of the New York Academy of Sciences, Vol. 282 ( R. L. Dornbush, A. M. Freedman, and M. Fink, Eds.), pp. 125–147. The New York Academy of Sciences, New York.Google Scholar
  79. Wikler, A., Williams, E. G., Douglass, E. D., Emmons, C. W., and Dunn, R. D., 1942, Mycotic endocarditis: Report of a case, J. Amer. Med. Ass.119: 33–36.CrossRefGoogle Scholar
  80. Wikler, A., Williams, E. G., and Wiesel, C. S., 1943, Monilemia associated with toxic purpura, Arch. Neurol. Psychiat. (Chicago) 50: 661–668.Google Scholar
  81. Wikler, A., Pescor, F. T., Fraser, H. F., and Isbell, H., 1956, Electroencephalographic changes associated with chronic alcoholic intoxication and the alcohol abstinence syndrome, Amer. J. Psychiat.113: 106–114.PubMedGoogle Scholar
  82. Winokur, A., Rickels, K., Greenblatt, D. J., Snyder, P. J., and Schatz, N. J., 1980, Withdrawal reaction from long-term, low-dosage administration of diazepam, Arch. Gen. Psychiat.37: 101–105.PubMedCrossRefGoogle Scholar
  83. Wolbach, A. B., Miner, E. J. and Isbell, H., 1962a, Comparison of psilocin with psilocybin, mescaline and LSD-25, Psychopharmacologia 3: 219–223.CrossRefGoogle Scholar
  84. Wolbach, A. B., Isbell, H., and Miner, E. J., 1962b, Cross tolerance between mescaline and LSD-25, with a comparison of the mescaline and LSD reactions, Psychopharmacologia 3: 1–14.CrossRefGoogle Scholar
  85. World Almanac and Book of Facts, 1979. Newspaper Enterprise Association, Inc., New York.Google Scholar
  86. Wulff, M. H., 1959, The barbiturate withdrawal syndrome. A clinical and electroencephalographic study, Electroenceph. Clin. Neurophysiol. Suppl. 14: 1–173.Google Scholar

Copyright information

© Plenum Press, New York 1980

Authors and Affiliations

  • Abraham Wikler
    • 1
  1. 1.Department of PsychiatryUniversity of Kentucky Medical CenterLexingtonUSA

Personalised recommendations